PVLA
Palvella Therapeutics
PVLA
PVLA
63 hedge funds and large institutions have $36.7M invested in Palvella Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $40.1M → $36.7M (-$3.41M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Holders
63
Holding in Top 10
1
Calls
$88K
Puts
$21K
Top Buyers
| 1 | +$3.26M | |
| 2 | +$2.2M | |
| 3 | +$537K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$501K |
| 5 |
Millennium Management
New York
|
+$416K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$2.26M | |
| 3 | -$976K | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$125K |
| 5 |
Cerity Partners
New York
|
-$114K |